Trial Profile
Effects of dalfampridine on mobility in the context of daily life
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 08 Oct 2015
Price :
$35
*
At a glance
- Drugs Fampridine (Primary)
- Indications Neurologic gait disorders
- Focus Therapeutic Use
- Sponsors Biogen
- 08 Oct 2015 New trial record